drugset / Trial / NCT01046292

Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI

NCT01046292

Phase 4 Completed 50 enrolled University Hospital, Basel, Switzerland
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to evaluate the effects of Ginkgo Biloba Extract (GBE) in executive function-impaired Mild Cognitive Impairment (MCI) patients by assessing gait while walking alone as well as under differing dual-task conditions. The primary endpoint in the evaluation of GBE efficacy is gait speed. The secondary endpoint is cycle time variability under dual-task conditions.

Timeline

Start
2010-01
Primary completion
2015-02
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 120 mg